Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria. (2018)


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkx467

PubMed Identifier: 29244108

Publication URI: http://europepmc.org/abstract/MED/29244108

Type: Journal Article/Review

Volume: 73

Parent Publication: The Journal of antimicrobial chemotherapy

Issue: 3

ISSN: 0305-7453